Western Standard LLC’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Western Standard LLC’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-424,080	Closed	-$8.6M	–	39
2022 Q4	$8.6M	Buy	+424,080	New	+$6.5M	7.57%	3

Western Standard LLC's OPNT Position: Q1 2023 in Review

Western Standard LLC sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 424,080 shares — an estimated $8.6M sold.

Western Standard LLC first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $8.6M in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

Western Standard LLC reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Western Standard LLC sold 424,080 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $8.6M.
Western Standard LLC first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Western Standard LLC's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $8.6M in Q4 2022.
0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Western Standard LLC's 13F filing for Q1 2023, filed 15 May 2023.